WINDTREE THERAPEUTICS INC (WINT)
US97382D5014 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.485M -27.28% | 1.788M 20.40% | 198K -88.93% | -100.00% | 7.727M | N/A | 89.046M | 205.12M 130.35% | ||||||||
| EBITDA YoY % growth | -22.356M 40.83% | -16.036M 28.27% | -24.698M -54.02% | N/A -22.08% | N/A -6.35% | N/A 33.40% | N/A 18.26% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -22.548M 40.72% | -16.195M 28.18% | -24.893M -53.71% | -31.651M -21.79% | -72.384M -6.41% | -35.006M 32.15% | -20.91M 19.87% | -19.89M -13.40% | -28.05M -41.03% | -36.108M -28.73% | -41.106M -13.84% | -48.144M -17.12% | -54.876M -13.98% | 22.032M 140.15% | 122.91M 457.87% | |
| Operating Margin | -1,518.38% | -905.76% | -12,572.22% | N/A | N/A | -453.04% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 24.74% | 59.92% | |
| EPS YoY % growth | N/A | N/A | N/A | -1.28 | -130.31 -5,115.69% | -0.99 98.51% | -5.38 -708.57% | -2.43 69.66% | -2.17 10.50% | -0.62 71.36% | -11.57 -1,759.02% | -13.04 -12.70% | -14.87 -14.08% | 4.22 128.40% | 23.32 452.17% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.16 -57.14% | -0.20 63.64% | -0.11 99.46% | -0.06 98.90% | 0.02 101.75% |
| Revenue Q2Q % growth | 2.244M | 3.06M | 3.264M | 3.876M | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.018M -21.36% | -1.856M 57.86% | -1M 91.27% | -581.4K 87.87% | 132.6K 102.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -5.54 -544.19% | -2.32 | -3.22 | -139.27% |
| Q2 2024 Q2Q % growth | -20.91 -1,175.06% | -8.27 | -12.64 | -152.79% |
| Q1 2024 Q2Q % growth | 88.21% | -0.56 | % | |
| Q4 2023 Q2Q % growth | -0.74 -245.47% | -0.96 | 0.22 | 22.82% |
| Q3 2023 Q2Q % growth | -0.86 86.77% | -0.64 | -0.22 | -33.83% |
| Q2 2023 Q2Q % growth | -1.64 83.60% | -0.69 | -0.95 | -136.45% |
| Q1 2023 Q2Q % growth | -4.76 67.17% | -0.57 | -4.19 | -733.33% |
| Q4 2022 Q2Q % growth | 99.18% | -0.21 | % | |
| Q3 2022 Q2Q % growth | -6.50 58.06% | -13.26 | 6.76 | 50.98% |
| Q2 2022 Q2Q % growth | -10.00 -2,100.00% | -9.18 | -0.82 | -8.93% |
| Q1 2022 Q2Q % growth | -14.50 43.14% | -15.30 | 0.80 | 5.23% |
| Q4 2021 Q2Q % growth | -26.00 -20.93% | -15.30 | -10.70 | -69.93% |
| Q3 2021 Q2Q % growth | -15.50 42.59% | -14.79 | -0.71 | -4.80% |
| Q2 2021 Q2Q % growth | 0.50 101.59% | -24.74 | 25.24 | 102.02% |
| Q1 2021 Q2Q % growth | -25.50 | -15.30 | -10.20 | -66.67% |
| Q4 2020 Q2Q % growth | -21.50 | -22.70 | 1.20 | 5.27% |
| Q3 2020 Q2Q % growth | -27.00 | -24.74 | -2.27 | -9.16% |
| Q2 2020 Q2Q % growth | -31.50 | -18.36 | -13.14 | -71.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 102K | -102K | -100.00% | |
| Q3 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q2 2022 Q2Q % growth | 102K | -102K | -100.00% | |
| Q1 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q2 2020 Q2Q % growth | -100.00% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |